Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Alex Brandon / AP
There's another way the Trump administration could kill Obamacare: creating uncertainty around government funding of cost-sharing reductions, which could throw insurers' future participation in state exchanges into question, per WaPo.
Where it stands: The Trump administration has said it will keep paying for the cost-sharing subsidies while a lawsuit against the measure, introduced by congressional Republicans, is being resolved, but insurers need to know what's going to happen after it's resolved.
Why it matters: If the federal government doesn't fund the $10 billion toward cost-sharing reductions in 2018, premiums could rise significantly — the Kaiser Family Foundation estimates a rise of 19 percent — or insurers could pull out of the exchanges altogether.